Press Releases

Toronto, Ontario--(Newsfile Corp. - June 5, 2024) - New World Solutions Inc. (CSE: NEWS) (OTC Pink: REGRF) (FSE: RT5) ("NEWS" or "New World" or the "Company") is pleased to announce that the Company has entered into an amended and restated share exchange agreement dated June 4, 2024 (the "Agreement") with Panyo AI Technologies Inc. ("Panyo"), a private British Columbia company, and the shareholders of Panyo (the "Shareholders") to acquire 100% of the issued and... (continue reading...)

NORTHAMPTON, MA / ACCESSWIRE / June 5, 2024 / Emma was a 28-year-old nursing student when she was diagnosed with triple-negative breast cancer. She had always wanted children and, once she learned that her treatment could affect her fertility, she found herself needing to make a quick family planning decision to pursue in vitro fertilization (IVF) and freeze her eggs.

"You think that you have time to have all these things happen, and you don't," says Emma. "Your life is... (continue reading...)

TORONTO, June 5, 2024 /PRNewswire/ - Hydro One Limited (Hydro One) (TSX: H), in accordance with Toronto Stock Exchange requirements, announced the voting results from its annual meeting of shareholders (AGM) held virtually on June 5, 2024.

A total of 492,430,079 shares representing 82.15% of Hydro One's issued and outstanding common shares were voted... (continue reading...)

IRVINE, Calif., June 5, 2024 /PRNewswire/ -- ACS Diagnostics, Inc. of Irvine CA, with executive offices in Chattanooga TN, has been granted U.S Patent No. 11,980,452. The patent relates to ACSD's Cardiac Monitoring CORE technology, specifically ambulatory ECG. The patented CORE device provides for multiple telemedicine related tests , including ECG/EKG, Holter, Event, and Mobile Cardiac Telemetry. The Core monitor integrates a cell phone module to alleviate the... (continue reading...)

BROSSARD, Quebec, June 05, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence (AI) technologies, announces the closing of a second and final tranche of 3,502,931 units (each a “Unit”) issued at a price of $0.28 per Unit, for gross proceeds of $980,820.68, of a non-brokered private placement initially... (continue reading...)